Federal Contractor Profile
International Aids Vaccine Initiative INC.
$153.7M obligated·31 awards·2 agencies·3 NAICS
Federal Contracts
Showing contracts 1–50 of 61 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Apr 10, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541715 | PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS | $3.4M |
| Aug 6, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50121C00077 | 541714 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN | $1.6M |
| Jul 31, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541714 | CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING | $70K |
| Jun 26, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93018F00002 | 541714 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL | $137K |
| May 13, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541715 | PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS | $209K |
| Apr 17, 2024 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $960K |
| Dec 11, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541714 | CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING | $2.1M |
| Dec 7, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541715 | PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS | $472K |
| Sep 26, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541714 | CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING | $1.5M |
| Sep 19, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00003 | 541714 | 1800010I IAVI BASE AWARD $810,077 FY20 CELL LINE OPTIMIZATION AND PRE-MASTER BANK GENERATION FOR SB 301, A VACCINE FOR HEPATITIS B VIRUS (HBV) TOVM20V24VB 2 IID CAN 8470036 | $21K |
| Sep 13, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00239 | 541712 | THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF | $382K |
| Aug 16, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $1.0M |
| Jul 21, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50121C00077 | 541714 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN | $18.3M |
| Jun 7, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00239 | 541712 | THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF | $253K |
| May 4, 2023 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $3.2M |
| Feb 8, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00003 | 541714 | 1800010I IAVI BASE AWARD $810,077 FY20 CELL LINE OPTIMIZATION AND PRE-MASTER BANK GENERATION FOR SB 301, A VACCINE FOR HEPATITIS B VIRUS (HBV) TOVM20V24VB 2 IID CAN 8470036 | $190K |
| Jan 10, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50121C00077 | 541714 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN | $29.8M |
| Dec 1, 2022 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $1.1M |
| Sep 15, 2022 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $5.3M |
| Sep 12, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50121C00077 | 541714 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN | $17.2M |
| Aug 30, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541715 | PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS | $4.0M |
| Jun 6, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00240 | 541712 | COORDINATION AND TECHNICAL SUPPORT | $181K |
| Dec 2, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00239 | 541712 | THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF | $20K |
| Dec 1, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541715 | PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS | $3K |
| Sep 30, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50121C00077 | 541714 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN | $28.7M |
| Sep 14, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00001 | 541714 | HHSN272201800010I IAVI STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID BASE AWARD, CAN 8470038 FOR $435,313.50 CAN 8040917 FOR $435,313.50 TOTAL $870,627 | $871K |
| Sep 10, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00003 | 541714 | 1800010I IAVI BASE AWARD $810,077 FY20 CELL LINE OPTIMIZATION AND PRE-MASTER BANK GENERATION FOR SB 301, A VACCINE FOR HEPATITIS B VIRUS (HBV) TOVM20V24VB 2 IID CAN 8470036 | $77K |
| Aug 31, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00239 | 541712 | THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF | $1.6M |
| Jul 7, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00240 | 541712 | COORDINATION AND TECHNICAL SUPPORT | $178K |
| Jun 30, 2021 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $7.7M |
| Apr 26, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00257 | 541712 | NANOPARTICLE-BASED DEVELOPMENT FOR HIV-1 BIOMOLECULE DELIVERY | $69K |
| Apr 5, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00131 | 541714 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953 | $666K |
| Dec 23, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $1.1M |
| Dec 7, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $5.8M |
| Oct 5, 2020 | Department of DefenseDEFENSE THREAT REDUCTION AGENCY | HDTRA121C0005 | 541715 | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | $6.5M |
| Sep 22, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00003 | 541714 | 1800010I IAVI BASE AWARD $810,077 FY20 CELL LINE OPTIMIZATION AND PRE-MASTER BANK GENERATION FOR SB 301, A VACCINE FOR HEPATITIS B VIRUS (HBV) TOVM20V24VB 2 IID CAN 8470036 | $810K |
| Sep 22, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93018F00002 | 541714 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL | $97K |
| Jul 10, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00001 | 541712 | COORDINATION AND TECHNICAL SUPPORT | $261K |
| May 8, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00002 | 541714 | IAVI BASE AWARD FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID-19 CAN 8044363 $21,065.00 | $21K |
| May 8, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00001 | 541714 | INTERNATIONAL AIDS VACCINE INITIATIVE FY20 BASE AWARD PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS COV 2 COV CAN 8044363 TOTAL $20,264.00 | $20K |
| Aug 23, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00270 | 541712 | ANTIGEN-ADJUVANT FORMULATION AND CHARACTERIZATION STUDIES | $1.1M |
| Aug 12, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00269 | 541712 | PROCESS DEVELOPMENT FOR CELL CULTURE, UPSTREAM AND DOWNSTREAM PROCESS IN PRODUCTION OF HIV-1 BIOMOLECULES | $1.7M |
| Aug 9, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00257 | 541712 | NANOPARTICLE-BASED DEVELOPMENT FOR HIV-1 BIOMOLECULE DELIVERY | $645K |
| Aug 8, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00132 | 541712 | PROCESS AND ASSAY DEVELOPMENT FOR CGMP PRODUCTION AND CHARACTERIZATION OF A VSV CANDIDATE | $949K |
| Jul 11, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00131 | 541712 | COORDINATION AND TECHNICAL SUPPORT | $458K |
| Jun 11, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00131 | 541714 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953 | $654K |
| Jun 3, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93018F00002 | 541714 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL | $1.2M |
| Feb 28, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00131 | 541714 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953 | $643K |
| Aug 28, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93018F00002 | 541714 | 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL | $2.8M |
| Jul 31, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN272201700003C | 541712 | IGF::OT::IGF STAGED VACCINE DEVELOPMENT: IMMUNOPROPHYLAXIS BY GENE TRANSFER | $700K |
Get Alerted Before International Aids Vaccine Initiative INC.'s Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free